 "Dr Reddy's")
Dr Reddy's Laboratories expects to launch 25 products in the US market in the current financial year, according to a top company official.
The drug major has also earmarked a capital expenditure (capex) of Rs 1,000 crore for finding various projects during the ongoing financial year.
"On a full-year basis (2019-20), we launched 27 products, including four re-launch of the earlier discontinued products. We expect the new launches momentum to continue during the year with about 25 product launches lined up despite uncertainty due to Covid-19," Dr Reddy's Laboratories CEO Erez Israeli said in an analyst call.
As of March
